在化学放射治疗后长期缓解的局部性血淋巴瘤与性结肠炎
Kentaro Hara1, Rina Hosoda1, Masaya Maegaki1
1Division of Hematology and Clinical Laboratory Medicine, Department of Multidisciplinary Internal Medicine, Faculty of Medicine, Tottori University, Japan.
Internal medicine (Tokyo, Japan)
|August 27, 2025
概括
血性淋巴瘤 (PBL) 是一种罕见的癌症,可能发生在性结肠炎 (UC) 患者中. 这项病例研究强调了化疗和放射治疗的成功,为UC相关PBL的长期存活提供了希望.
科学领域:
- 癌症学
- 胃肠病学
- 血液学
背景情况:
- 血性淋巴瘤 (PBL) 是一种侵袭性的B细胞淋巴瘤,通常与艾滋病毒有关.
- 在性结肠炎 (UC) 背景下发生的PBL非常罕见.
- 长期治疗UC,如梅萨拉和布德索尼德,正在研究与二次恶性瘤的潜在关联.
研究的目的:
- 在患有性结肠炎的HIV阴性患者中报告一种极为罕见的结肠血淋巴瘤 (PBL).
- 讨论这种罕见疾病的治疗和长期结果.
- 对UC患者局部PBL的化学放射治疗的潜在疗效进行评估.
主要方法:
- 一个63岁的HIV阴性妇女的病例报告.
- 在长期使用梅萨拉和布德索尼德治疗后诊断结肠PBL.
- 用化疗和腹部放射治疗进行治疗
主要成果:
- 患者的结肠PBL完全缓解.
- 在治疗后的三年内,没有观察到复发.
- 这是第四个与UC相关的PBL病例,也是迄今为止最长的存活期.
结论:
- 即使在用梅萨拉和布德索尼德治疗后,艾滋病毒阴性UC患者也可能发生PBL.
- 化学辐射疗法似乎是局部PBL的有效治疗方式.
- 这一病例提供了关于这种罕见的癌症并发症的长期存活和治疗的有价值的数据.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
236
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
236
Inflammatory Bowel Disease V: Surgical Management
206
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
206
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
413
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
413
Inflammatory Bowel Disease I: Ulcerative Colitis
316
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
316
Chronic Bowel Disorders: Introduction
540
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
540
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
264
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
264


